Opaleye Management

Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 6
Average round size
The average size of a deal this fund participated in
Portfolio companies 6
Lead investments 0
Exits 2
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Medical Device
  • Manufacturing
  • Health Diagnostics

The typical case for the fund is to invest in rounds with 8 participants. Despite the Opaleye Management, startups are often financed by OrbiMed, GE Ventures, Xeraya Capital. The meaningful sponsors for the fund in investment in the same round are Xeraya Capital, Pura Vida Investments, OrbiMed. In the next rounds fund is usually obtained by Royalties Fund, OrbiMed, Deerfield Capital Management.

The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2019. Deals in the range of more than 100 millions dollars are the general things for fund.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Acutus Medical.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Opaleye Management:
Typical Co-investors
Opaleye Management is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Opaleye Management:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AVRO Accelerator Australia, New South Wales, Sydney
Bahrain Development Bank Bahrain, Capital Governorate, Manama
Chicagoland Investors Chicago, Illinois, United States
Conversion Ventures LLC New York, New York, United States
Essence Securities China, Guangdong, Shenzhen
Frasers Property Central, Central Region, Singapore
HLD France, Ile-de-France, Paris
KEY Investment Partners Colorado, Denver, United States
Lavni Ventures -
Marc Bell Capital Boca Raton, Florida, United States
Paradigm Capital Partners Memphis, Tennessee, United States
Project 11 Ventures Boston, Massachusetts, United States
Shanghai Ruijian Capital Management Co. China, Shanghai
Shell Oil Company Houston, Texas, United States
Solidus Company Nashville, Tennessee, United States
TGZ Capital New York, New York, United States
Ultrabuttonwood Capital Beijing, Beijing, China
Xtreme Labs California, Palo Alto, United States
ZIM Canada, Ontario, Ottawa

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

IpiNovyx Bio

$10M05 Oct 2021 New York, New York, United States

Health Care
$80M20 Apr 2021 Connecticut, United States


Health Care
$79M08 Apr 2021 Bethesda, Maryland, United States

Palvella Therapeutics

Health Care
Life Science
$45M28 May 2020 Radnor Township, Pennsylvania, United States


Health Care
Medical Device
$25M08 Aug 2019 City of Saint Louis, Missouri, United States

Acutus Medical

Health Care
Health Diagnostics
Medical Device
$100M20 Jun 2019 Carlsbad, California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Opaleye Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: